ArticleNature communications2026
Robust characterization and interpretation of rare pathogenic cell populations from spatial omics using GARDEN.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ARISE: RNA-anchored shared-edge topology and hierarchical fusion for spatial multi-omics integration.Bioinformatics (Oxford, England) · 2026Article
- Robust characterization and interpretation of rare pathogenic cell populations from spatial omics using GARDEN.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Spatial omics links molecular measurements to their positions in tissue, revealing cellular organization and interactions. Yet most computational tools highlight common cell types and overlook rare populations that can drive disease. Here we show GARDEN, a computational framework that identifies and characterizes these pathogenic cells or regions in spatial omics by embedding graph-based dynamic attention into a spatially-aware graph fusion contrastive model. GARDEN works consistently across tissues, species and resolution scales, and aligns consecutive sections to reconstruct 3D anatomy. In an Alzheimer's disease model, GARDEN localizes C1qa/C1qb-marked microglia in amyloid-β regions and reveals key immune pathways. In nasopharyngeal carcinoma it identifies tiny tertiary lymphoid structures, and in breast cancer it uncovers inflammatory M1-like macrophages near ductal carcinoma in situ and links them to pro-metastatic signaling. An interpretation module pinpoints key immune signatures, and GARDEN extends to spatial chromatin accessibility, providing insight into epigenetic regulation and informing diagnostics and therapeutic targeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.